Primary Site >> Biliary tract Cancer
Gene >> EPHB2
| 1. | |||||||||||
| Journal: | Gut. 2003 May;52(5):706-12. | ||||||||||
| Title: | Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. | ||||||||||
| Author: | Tannapfel, A|Sommerer, F|Benicke, M|Katalinic, A|Uhlmann, D|Witzigmann, H|Hauss, J|Wittekind, C | ||||||||||
| PMID: | 12692057 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Oncol. 2006 Apr;28(4):915-21. | ||||||||||
| Title: | The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines. | ||||||||||
| Author: | Miyata, Hideki|Sasaki, Tamito|Kuwahara, Kenichi|Serikawa, Masahiro|Chayama, Kazuaki | ||||||||||
| PMID: | 16525641 | ||||||||||
| 3. | |||||||||||
| Journal: | J Surg Res. 2006 Nov;136(1):78-84. Epub 2006 Sep 1. | ||||||||||
| Title: | Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met. | ||||||||||
| Author: | Leelawat, Kawin|Leelawat, Surang|Tepaksorn, Panada|Rattanasinganchan, Panthip|Leungchaweng, Anicha|Tohtong, Rutaiwan|Sobhon, Prasert | ||||||||||
| PMID: | 16950403 | ||||||||||
| 4. | |||||||||||
| Journal: | J Clin Invest. 2006 Jul;116(7):1843-52. Epub 2006 Jun 8. | ||||||||||
| Title: | Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. | ||||||||||
| Author: | Xu, Xiaoling|Kobayashi, Shogo|Qiao, Wenhui|Li, Cuiling|Xiao, Cuiying|Radaeva, Svetlana|Stiles, Bangyan|Wang, Rui-Hong|Ohara, Nobuya|Yoshino, Tadashi|LeRoith, Derek|Torbenson, Michael S|Gores, Gregory J|Wu, Hong|Gao, Bin|Deng, Chu-Xia | ||||||||||
| PMID: | 16767220 | ||||||||||
| 5. | |||||||||||
| Journal: | Mol Cell Biochem. 2007 Nov;305(1-2):19-26. Epub 2007 Jun 6. | ||||||||||
| Title: | Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling. | ||||||||||
| Author: | Zhang, Li|Jiang, Li|Sun, Qiuyan|Peng, Tao|Lou, Kexin|Liu, Ningbo|Leng, Jing | ||||||||||
| PMID: | 17551669 | ||||||||||
| 6. | |||||||||||
| Journal: | Hepatogastroenterology. 2007 Jul-Aug;54(77):1339-44. | ||||||||||
| Title: | Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma. | ||||||||||
| Author: | Ailawadhi, Sikander|Nagase, Hiroki|Khoury, Thaer|Yu, Jihnhee|Tan, Dongfeng|Black, Jennifer|Brattain, Michael|Javle, Milind | ||||||||||
| PMID: | 17708250 | ||||||||||
| 7. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2009 May 18;28:65. | ||||||||||
| Title: | Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations. | ||||||||||
| Author: | Li, Qinglong|Yang, Zhulin | ||||||||||
| PMID: | 19445727 | ||||||||||
| 8. | |||||||||||
| Journal: | Dig Dis Sci. 2010 Oct;55(10):2844-52. | ||||||||||
| Title: | The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells. | ||||||||||
| Author: | Duan, Shi-Gang|Cheng, Long|Li, Da-Jiang|Zhu, Jin|Xiong, Yan|Li, Xiao-Wu|Wang, Shu-Guang | ||||||||||
| PMID: | 20101459 | ||||||||||
| 9. | |||||||||||
| Journal: | Curr Drug Targets. 2010 Jul;11(7):834-50. | ||||||||||
| Title: | Molecular targeted therapy of biliary tract cancer--results of the first clinical studies. | ||||||||||
| Author: | Wiedmann, Marcus W|Mossner, Joachim | ||||||||||
| PMID: | 20388063 | ||||||||||
| 10. | |||||||||||
| Journal: | J Gastroenterol. 2011 May;46(5):664-75. | ||||||||||
| Title: | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. | ||||||||||
| Author: | Namwat, N|Puetkasichonpasutha, J|Loilome, W|Yongvanit, P|Techasen, A|Puapairoj, A|Sripa, B|Tassaneeyakul, W|Khuntikeo, N|Wongkham, S | ||||||||||
| PMID: | 21076843 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Sci. 2012 Feb;103(2):252-61. | ||||||||||
| Title: | Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers. | ||||||||||
| Author: | Ohashi, Hirokazu|Adachi, Yasushi|Yamamoto, Hiroyuki|Taniguchi, Hiroaki|Nosho, Katsuhiko|Suzuki, Hiromu|Arimura, Yoshiaki|Imai, Kohzoh|Carbone, David P|Shinomura, Yasuhisa | ||||||||||
| PMID: | 22044563 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Lett. 2012 Mar;316(1):70-6. | ||||||||||
| Title: | L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells. | ||||||||||
| Author: | Yoon, Hyunho|Min, Jeong-Ki|Lee, Dong Gwang|Kim, Dae-Ghon|Koh, Sang Seok|Hong, Hyo Jeong | ||||||||||
| PMID: | 22088438 | ||||||||||
| 13. | |||||||||||
| Journal: | J Hepatol. 2012 Oct;57(4):813-20. | ||||||||||
| Title: | Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. | ||||||||||
| Author: | Gentilini, Alessandra|Rombouts, Krista|Galastri, Sara|Caligiuri, Alessandra|Mingarelli, Eleonora|Mello, Tommaso|Marra, Fabio|Mantero, Stefano|Roncalli, Massimo|Invernizzi, Pietro|Pinzani, Massimo | ||||||||||
| PMID: | 22727731 | ||||||||||
| 14. | |||||||||||
| Journal: | Int J Oncol. 2013 Feb;42(2):690-8. | ||||||||||
| Title: | Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma. | ||||||||||
| Author: | Yang, Wei|Wang, Xiaoyuan|Zheng, Wei|Li, Kedong|Liu, Haofeng|Sun, Yueming | ||||||||||
| PMID: | 23254774 | ||||||||||
| 15. | |||||||||||
| Journal: | ISRN Hepatol. 2013 Nov 17;2013:601071. | ||||||||||
| Title: | Protective Effects of Guava Pulp on Cholestatic Liver Injury. | ||||||||||
| Author: | Peng, Jian|Yue, Chunyan|Qiu, Kai|Chen, Jie|Aller, Maria-Angeles|Ko, Kwang Suk|Yang, Heping | ||||||||||
| PMID: | 27335829 | ||||||||||
| 16. | |||||||||||
| Journal: | J Pathol. 2013 Jun;230(2):165-73. | ||||||||||
| Title: | PTEN loss and KRAS activation cooperate in murine biliary tract malignancies. | ||||||||||
| Author: | Marsh, Victoria|Davies, Emma J|Williams, Geraint T|Clarke, Alan R | ||||||||||
| PMID: | 23483557 | ||||||||||
| 17. | |||||||||||
| Journal: | Oncol Rep. 2014 Jan;31(1):145-52. | ||||||||||
| Title: | Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study. | ||||||||||
| Author: | Li, Shuai|Han, Zhiyang|Ma, Yong|Song, Ruipeng|Pei, Tiemin|Zheng, Tongsen|Wang, Jiabei|Xu, Dongsheng|Fang, Xiang|Jiang, Hongchi|Liu, Lianxin | ||||||||||
| PMID: | 24247752 | ||||||||||
| 18. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2014 Jan 15;7(2):521-8. eCollection 2014. | ||||||||||
| Title: | Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine. | ||||||||||
| Author: | Yang, Chao|Xu, Ming|Shen, Huo-Jian|Zhu, Hong-Yi|Li, Fu|He, Min|Chen, Tao|Wang, Jian|Shi, Wei-Jin|Ji, Fu | ||||||||||
| PMID: | 24551272 | ||||||||||
| 19. | |||||||||||
| Journal: | Oncol Rep. 2014 Jun;31(6):2611-8. | ||||||||||
| Title: | Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines. | ||||||||||
| Author: | Ling, Sunbin|Feng, Tingting|Ke, Qinghong|Fan, Ning|Li, Lei|Li, Zhongxing|Dong, Chengyong|Wang, Cong|Xu, Fei|Li, Yan|Wang, Liming | ||||||||||
| PMID: | 24788596 | ||||||||||
| 20. | |||||||||||
| Journal: | Tumour Biol. 2014 Oct;35(10):10031-41. | ||||||||||
| Title: | Increased EphB2 expression predicts cholangiocarcinoma metastasis. | ||||||||||
| Author: | Khansaard, Walaiporn|Techasen, Anchalee|Namwat, Nisana|Yongvanit, Puangrat|Khuntikeo, Narong|Puapairoj, Anucha|Loilome, Watcharin | ||||||||||
| PMID: | 25012246 | ||||||||||
| 21. | |||||||||||
| Journal: | Invest New Drugs. 2014 Dec;32(6):1144-54. | ||||||||||
| Title: | Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors. | ||||||||||
| Author: | Ewald, Florian|Norz, Dominik|Grottke, Astrid|Hofmann, Bianca T|Nashan, Bjorn|Jucker, Manfred | ||||||||||
| PMID: | 25152244 | ||||||||||
| 22. | |||||||||||
| Journal: | J Liver. 2014 Jul;3(3). | ||||||||||
| Title: | Fibroblast Growth Factor 19 Activates the Unfolded Protein Response and Mitogen-Activated Protein Kinase Phosphorylation in H-69 Cholangiocyte Cells. | ||||||||||
| Author: | Qureshi, Hannan A|Pearl, Jeffrey A|Anderson, Kristy A|Green, Richard M | ||||||||||
| PMID: | 29093991 | ||||||||||
| 23. | |||||||||||
| Journal: | Int J Clin Exp Med. 2015 Oct 15;8(10):17781-8. eCollection 2015. | ||||||||||
| Title: | Pachymic acid inhibits tumorigenesis in gallbladder carcinoma cells. | ||||||||||
| Author: | Chen, Yueguang|Lian, Peilong|Liu, Yanfeng|Xu, Kesen | ||||||||||
| PMID: | 26770369 | ||||||||||
| 24. | |||||||||||
| Journal: | Tumour Biol. 2015 Jul;36(7):5171-7. | ||||||||||
| Title: | Loss of angiotensin-converting enzyme 2 promotes growth of gallbladder cancer. | ||||||||||
| Author: | Zong, Huajie|Yin, Baobing|Zhou, Huading|Cai, Duan|Ma, Baojin|Xiang, Yang | ||||||||||
| PMID: | 25663464 | ||||||||||
| 25. | |||||||||||
| Journal: | Oncotarget. 2015 Sep 15;6(27):23594-608. | ||||||||||
| Title: | Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. | ||||||||||
| Author: | Chen, Ming-Huang|Yen, Chueh-Chuan|Cheng, Chi-Tung|Wu, Ren-Chin|Huang, Shih-Chiang|Yu, Chung-Shan|Chung, Yi-Hsiu|Liu, Chun-Yu|Chang, Peter Mu-Hsin|Chao, Yee|Chen, Ming-Han|Chen, Yu-Fen|Chiang, Kun-Chun|Yeh, Ta-Sen|Chen, Tzu Chi|Huang, Chi-Ying F|Yeh, Chun- | ||||||||||
| PMID: | 26090720 | ||||||||||
| 26. | |||||||||||
| Journal: | Gut Liver. 2016 Mar;10(2):310-7. | ||||||||||
| Title: | Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells. | ||||||||||
| Author: | Lee, Jin|Hong, Eun Mi|Jang, Ju Ah|Park, Se Woo|Koh, Dong Hee|Choi, Min Ho|Jang, Hyun Joo|Kae, Sea Hyub | ||||||||||
| PMID: | 26470769 | ||||||||||
| 27. | |||||||||||
| Journal: | J Gastroenterol. 2016 Jul;51(7):711-21. | ||||||||||
| Title: | A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks. | ||||||||||
| Author: | Mohri, Dai|Ijichi, Hideaki|Miyabayashi, Koji|Takahashi, Ryota|Kudo, Yotaro|Sasaki, Takashi|Asaoka, Yoshinari|Tanaka, Yasuo|Ikenoue, Tsuneo|Tateishi, Keisuke|Tada, Minoru|Isayama, Hiroyuki|Koike, Kazuhiko | ||||||||||
| PMID: | 26614007 | ||||||||||
| 28. | |||||||||||
| Journal: | Cell Mol Neurobiol. 2016 Oct;36(7):1097-107. | ||||||||||
| Title: | Downregulation of lncRNA-MALAT1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S. | ||||||||||
| Author: | Han, Yong|Zhou, Liang|Wu, Tingfeng|Huang, Yulun|Cheng, Zhe|Li, Xuetao|Sun, Ting|Zhou, Youxin|Du, Ziwei | ||||||||||
| PMID: | 26649728 | ||||||||||
| 29. | |||||||||||
| Journal: | Oncotarget. 2016 Feb 2;7(5):5306-12. | ||||||||||
| Title: | Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors. | ||||||||||
| Author: | Ahn, Daniel H|Ozer, Hatice Gulcin|Hancioglu, Baris|Lesinski, Gregory B|Timmers, Cynthia|Bekaii-Saab, Tanios | ||||||||||
| PMID: | 26683364 | ||||||||||
| 30. | |||||||||||
| Journal: | World J Gastroenterol. 2016 Feb 14;22(6):2071-80. | ||||||||||
| Title: | Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice. | ||||||||||
| Author: | Ding, Ning|Che, Li|Li, Xiao-Lei|Liu, Yan|Jiang, Li-Jie|Fan, Biao|Tao, Jun-Yan|Chen, Xin|Ji, Jia-Fu | ||||||||||
| PMID: | 26877611 | ||||||||||
| 31. | |||||||||||
| Journal: | Int J Oncol. 2016 May;48(5):2025-34. | ||||||||||
| Title: | Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. | ||||||||||
| Author: | Muller, Alena|Barat, Samarpita|Chen, Xi|Bui, Khac Cuong|Bozko, Przemyslaw|Malek, Nisar P|Plentz, Ruben R | ||||||||||
| PMID: | 26935541 | ||||||||||
| 32. | |||||||||||
| Journal: | Oncotarget. 2016 Apr 19;7(16):22339-54. | ||||||||||
| Title: | miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma. | ||||||||||
| Author: | Bao, Run-Fa|Shu, Yi-Jun|Hu, Yun-Ping|Wang, Xu-An|Zhang, Fei|Liang, Hai-Bin|Ye, Yuan-Yuan|Li, Huai-Feng|Xiang, Shan-Shan|Weng, Hao|Cao, Yang|Wu, Xiang-Song|Li, Mao-Lan|Wu, Wen-Guang|Zhang, Yi-Jian|Jiang, Lin|Dong, Qian|Liu, Ying-Bin | ||||||||||
| PMID: | 26968949 | ||||||||||
| 33. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2016 Apr 16;35:68. | ||||||||||
| Title: | Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. | ||||||||||
| Author: | Cao, Yang|Liang, Haibin|Zhang, Fei|Luan, Zhou|Zhao, Shuai|Wang, Xu-An|Liu, Shibo|Bao, Runfa|Shu, Yijun|Ma, Qiang|Zhu, Jian|Liu, Yingbin | ||||||||||
| PMID: | 27084680 | ||||||||||
| 34. | |||||||||||
| Journal: | PLoS One. 2016 Sep 14;11(9):e0162594. | ||||||||||
| Title: | Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation. | ||||||||||
| Author: | Hall, Terence G|Yu, Yi|Eathiraj, Sudharshan|Wang, Yunxia|Savage, Ronald E|Lapierre, Jean-Marc|Schwartz, Brian|Abbadessa, Giovanni | ||||||||||
| PMID: | 27627808 | ||||||||||
| 35. | |||||||||||
| Journal: | Oncotarget. 2016 Nov 8;7(45):72833-72844. | ||||||||||
| Title: | Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway. | ||||||||||
| Author: | Shen, Sheng|Liu, Han|Wang, Yueqi|Wang, Jiwen|Ni, Xiaolin|Ai, Zhilong|Pan, Hongtao|Liu, Houbao|Shao, Yebo | ||||||||||
| PMID: | 27637083 | ||||||||||
| 36. | |||||||||||
| Journal: | Biol Pharm Bull. 2017 Apr 1;40(4):495-503. | ||||||||||
| Title: | Growth Inhibition of Refractory Human Gallbladder Cancer Cells by Retinol, and Its Mechanism of Action. | ||||||||||
| Author: | Li, Chuan|Imai, Masahiko|Hasegawa, Shinya|Yamasaki, Masahiro|Takahashi, Noriko | ||||||||||
| PMID: | 28100868 | ||||||||||
| 37. | |||||||||||
| Journal: | Apoptosis. 2017 Nov;22(11):1473-1484. | ||||||||||
| Title: | Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. | ||||||||||
| Author: | Thongsom, Sunisa|Suginta, Wipa|Lee, Kyung Jin|Choe, Han|Talabnin, Chutima | ||||||||||
| PMID: | 28913568 | ||||||||||
| 38. | |||||||||||
| Journal: | Oncotarget. 2017 Apr 18;8(16):26169-26184. | ||||||||||
| Title: | Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer. | ||||||||||
| Author: | Weber, Helga|Valbuena, Jose R|Barbhuiya, Mustafa A|Stein, Stefan|Kunkel, Hana|Garcia, Patricia|Bizama, Carolina|Riquelme, Ismael|Espinoza, Jaime A|Kurtz, Stephen E|Tyner, Jeffrey W|Calderon, Juan Francisco|Corvalan, Alejandro H|Grez, Manuel|Pandey, Akhile | ||||||||||
| PMID: | 28412732 | ||||||||||
| 39. | |||||||||||
| Journal: | Pathol Res Pract. 2017 May;213(5):476-482. | ||||||||||
| Title: | The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer. | ||||||||||
| Author: | Buchegger, Kurt|Silva, Ramon|Lopez, Jaime|Ili, Carmen|Araya, Juan Carlos|Leal, Pamela|Brebi, Priscilla|Riquelme, Ismael|Roa, Juan Carlos | ||||||||||
| PMID: | 28285962 | ||||||||||
| 40. | |||||||||||
| Journal: | Mol Cancer Ther. 2017 Jun;16(6):1145-1154. | ||||||||||
| Title: | Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition. | ||||||||||
| Author: | Jin, Mei Hua|Nam, Ah-Rong|Park, Ji Eun|Bang, Ju-Hee|Bang, Yung-Jue|Oh, Do-Youn | ||||||||||
| PMID: | 28223426 | ||||||||||
| 41. | |||||||||||
| Journal: | Biochimie. 2017 Jan;132:152-160. | ||||||||||
| Title: | The emerging role of long non-coding RNA in gallbladder cancer pathogenesis. | ||||||||||
| Author: | Khandelwal, Akanksha|Malhotra, Akshay|Jain, Manju|Vasquez, Karen M|Jain, Aklank | ||||||||||
| PMID: | 27894946 | ||||||||||
| 42. | |||||||||||
| Journal: | Cytotechnology. 2018 Feb;70(1):439-448. | ||||||||||
| Title: | Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway. | ||||||||||
| Author: | Bi, Tingting|Zhu, Ao|Yang, Xufeng|Qiao, Huiying|Tang, Jinmei|Liu, Yan|Lv, Rong | ||||||||||
| PMID: | 29110119 | ||||||||||
| 43. | |||||||||||
| Journal: | Cell Death Dis. 2018 Jan 18;9(2):31. | ||||||||||
| Title: | Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model. | ||||||||||
| Author: | Dong, Mingjie|Liu, Xianqiong|Evert, Katja|Utpatel, Kirsten|Peters, Michele|Zhang, Shanshan|Xu, Zhong|Che, Li|Cigliano, Antonio|Ribback, Silvia|Dombrowski, Frank|Cossu, Antonio|Gordan, John|Calvisi, Diego F|Evert, Matthias|Liu, Yan|Chen, Xin | ||||||||||
| PMID: | 29348467 | ||||||||||
| 44. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2018 May 15;499(3):433-440. | ||||||||||
| Title: | Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation. | ||||||||||
| Author: | Chen, Jian|Song, Wenfeng|Du, Yehui|Li, Zequn|Xuan, Zefeng|Zhao, Long|Chen, Jun|Zhao, Yongchao|Tuo, Biguang|Zheng, Shusen|Song, Penghong | ||||||||||
| PMID: | 29574153 | ||||||||||
| 45. | |||||||||||
| Journal: | Cancer Lett. 2018 Aug 28;430:97-108. | ||||||||||
| Title: | EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway. | ||||||||||
| Author: | Ma, Qiang|Zhang, Yijian|Liang, Haibin|Zhang, Fei|Liu, Fatao|Chen, Shili|Hu, Yunping|Jiang, Lin|Hao, Yajuan|Li, Maolan|Liu, Yingbin | ||||||||||
| PMID: | 29778567 | ||||||||||
| 46. | |||||||||||
| Journal: | J Cell Mol Med. 2018 Aug 30. | ||||||||||
| Title: | Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling. | ||||||||||
| Author: | Xu, Yun-Fei|Liu, Hong-Da|Liu, Zeng-Li|Pan, Chang|Yang, Xiao-Qing|Ning, Shang-Lei|Zhang, Zong-Li|Guo, Sen|Yu, Jin-Ming | ||||||||||
| PMID: | 30160357 | ||||||||||
| 47. | |||||||||||
| Journal: | J Surg Res. 2018 Nov;231:116-125. | ||||||||||
| Title: | IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC. | ||||||||||
| Author: | Wang, Jian|Zhang, Zhan-Guo|Ding, Ze-Yang|Dong, Wei|Liang, Hui-Fang|Chu, Liang|Zhang, Bi-Xiang|Chen, Xiao-Ping | ||||||||||
| PMID: | 30278918 | ||||||||||
| 48. | |||||||||||
| Journal: | Int J Cancer. 2018 Oct 10. | ||||||||||
| Title: | ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in Early Stage Gallbladder Cancer. | ||||||||||
| Author: | Iyer, Prajish|Shrikhande, Shailesh V|Ranjan, Malika|Joshi, Asim|Gardi, Nilesh|Prasad, Ratnam|Dharavath, Bhasker|Thorat, Rahul|Salunkhe, Sameer|Sahoo, Bikram|Chandrani, Pratik|Kore, Hitesh|Mohanty, Bhabani|Chaudhari, Vikram|Choughule, Anuradha|Kawle, Dhana | ||||||||||
| PMID: | 30304546 | ||||||||||
| 49. | |||||||||||
| Journal: | Int J Mol Sci. 2018 Oct 12;19(10). pii: ijms19103141. | ||||||||||
| Title: | MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner. | ||||||||||
| Author: | Miao, Wenyu|Sakai, Katsuya|Imamura, Ryu|Ito, Kenichiro|Suga, Hiroaki|Sakuma, Tetsushi|Yamamoto, Takashi|Matsumoto, Kunio | ||||||||||
| PMID: | 30322054 | ||||||||||